Table of Contents

Orgovyx (relugolix) is the first FDA-approved oral gonadotropin-releasing hormone (GnRH) receptor antagonist for advanced prostate cancer. Because it is taken at home rather than as an injection, the way it is dosed matters.

Starting therapy with the correct loading dose and maintaining a consistent daily routine helps keep testosterone levels suppressed. Below, we’ll explain why the loading dose exists, outline common dosing errors, and offer tips to stay on track.

Key Takeaways

  • Start with the full loading dose. On day 1, you should take three 120 mg tablets (360 mg total) to quickly bring testosterone down.
  • Take one 120 mg tablet every day after the loading dose. The maintenance dose is one tablet taken orally at about the same time each day.
  • Never crush, chew, or split the tablet. The tablets should be swallowed whole. Food does not affect absorption.
  • If you miss a dose, take the missed tablet as soon as you remember, but skip it if more than 12 hours have passed and restart on schedule the next day.
  • If therapy stops for more than seven days, restart with the 360 mg loading dose and resume the daily 120 mg dose thereafter.

Recommended loading dose and maintenance dose of Orgovyx

Orgovyx dosing schedule for prostate cancer

Here’s how to take Orgovyx:

    • On the first day, you take a loading dose of 360 mg (three 120 mg tablets).
    • After that, you take 120 mg once daily, around the same time each day.
    • You can take it with or without food.
    • Swallow the tablets whole. Do not crush or chew them.

Why does Orgovyx use a loading dose?

The 360 mg loading dose is designed to suppress testosterone quickly so that the daily 120 mg maintenance dose can keep it to a very low level or castrate level. Similar to what would happen if the testicles were surgically removed.

In one study, patients received a 360 mg loading dose on day 1 and continued 120 mg daily. After 2 weeks, their testosterone levels were confirmed to be below 50 ng/dL (castrate level). Normal testosterone in adult men is usually about 300-1,000 ng/dL, so castrate levels are significantly lower.

Without the initial loading dose, testosterone suppression may be delayed, potentially affecting treatment outcomes.

What if you miss a dose?

If you remember the same day, take it as soon as you remember. If it has been more than 12 hours, skip that dose and take your next dose at the usual time.

Do not double up your dose.

What if you stop for more than 7 days?

If you miss Orgovyx for more than a week, you must restart with the 360 mg loading dose on the first day, then go back to 120 mg daily. This helps quickly lower testosterone again.

How long do you take Orgovyx for prostate cancer?

For men with advanced or metastatic prostate cancer, androgen deprivation therapy like Orgovyx is usually continued indefinitely. Even if the cancer becomes “castration-resistant” (meaning it grows despite low testosterone), doctors typically keep testosterone suppressed and add other treatments on top of it.

If Orgovyx is combined with radiation for high-risk localized prostate cancer, hormone therapy may be given for 6 months up to 2-3 years, as studies suggest longer treatment can improve outcomes in some patients.

If Orgovyx side effects become severe, treatment plans may change. In some intermittent therapy strategies, doctors may pause treatment under close monitoring.

Basically, the treatment duration depends on your risk level and clinical situation.

Drug interactions and dose modifications

Because relugolix is absorbed and broken down by specific transport proteins and liver enzymes in the body, certain medications can reduce its effectiveness or increase side effects. Below are important considerations:

1. P-gp inhibitors

P-glycoprotein (P-gp) inhibitors are medications that block a transport protein in the gut and liver. When blocked, drugs like Orgovyx can build up to higher levels in the body.

It’s best to avoid taking Orgovyx with an oral P-gp inhibitor. But if co-administration is unavoidable, take Orgovyx first, separate doses by at least six hours, and monitor for adverse reactions.

Here are common examples of P-gp inhibitors that you may encounter:

    • Common antibiotics (clarithromycin, erythromycin)
    • Antifungals (ketoconazole, itraconazole, posaconazole, voriconazole)
    • Heart medications (verapamil, diltiazem, amiodarone, quinidine)
    • HIV / antiviral medications (ritonavir, cobicistat)
    • Supplements (grapefruit, turmeric/curcumin)

If short-term therapy with a P-gp inhibitor is necessary, you can pause Orgovyx for up to two weeks. Once you stop the interfering medication, you can restart Orgovyx.

However, if Orgovyx has been stopped for more than 7 days, you must restart with the loading dose of 360 mg on the first day, then go back to the regular 120 mg once daily.

2. Combined P-gp and strong CYP3A inducers

These drugs can significantly lower relugolix levels, making Orgovyx less effective.

Here are the most clinically relevant examples:

    • rifampin (rifampicin)
    • carbamazepine
    • phenytoin
    • phenobarbital
    • St. John’s Wort

When co-administration cannot be avoided, increase the Orgovyx dose to 240 mg once daily. After discontinuation of the inducer, return to 120 mg daily.

3. Hormonal therapies and anti-androgens

In clinical studies, relugolix has been used with radiotherapy and with androgen-receptor blockers like enzalutamide (Xtandi). Any combination therapy should be supervised by an oncologist.

Always inform your healthcare provider about every prescription and over-the-counter medication, including herbal supplements, to avoid interactions.

Orgovyx coupons and discounts

Starts from $419.99

Have a prescription?

Choose Pharma Giant for affordable medications and take control of your health with reliable, cost-effective options today!

SAVE 10% with coupon code:

Can you take Orgovyx and Erleada together?

Yes. Orgovyx (relugolix) and Erleada (apalutamide) can be used together in certain cases, but there are important considerations.

Orgovyx lowers testosterone levels (androgen deprivation therapy). On the other hand, Erleada blocks the androgen receptor, preventing testosterone from stimulating prostate cancer cells. Together, this is called intensified hormonal therapy, often used for advanced or high-risk prostate cancer.

However, apalutamide is a strong CYP3A and P-gp inducer. That means it can:

    • Increase the breakdown of relugolix
    • Lower relugolix blood levels
    • Potentially reduce testosterone suppression

Because of this interaction, the relugolix dose may need to be increased to 240 mg once daily during co-administration.

A small study showed that the standard dose of relugolix (120 mg daily after loading) successfully kept testosterone at castrate levels even when combined with apalutamide. All patients maintained low testosterone without needing to increase the relugolix dose. The combination was generally well tolerated, with hot flashes being the most common side effect.

However, the study was small and short-term, so larger trials are needed to confirm long-term safety and effectiveness. Orgovyx dosing with Erleada must be managed by an oncologist.

Common Orgovyx dosing mistakes

Patients often make errors that can affect how well the drug works. Below are frequent mistakes and how to avoid them.

Skipping or under-dosing the loading dose

The loading dose ensures rapid hormone suppression. Failing to take all three tablets on day 1 or spreading them out over several days can delay castration. It is important to take the full 360 mg on the first day.

Taking multiple maintenance doses per day

After day 1, the dose drops to one tablet per day. Some patients mistakenly continue taking three tablets daily because they assume the higher dose continues. Doing so may increase the risk of side effects without improving effectiveness.

Not following the missed-dose rules

Missing a dose happens, but the way you handle it matters. The prescribing information advises taking a missed tablet as soon as you remember. However, if more than 12 hours have passed, skip the missed dose and resume the usual schedule the next day.

Do not double up to make up for a missed dose. Skipping too many doses in a row (longer than one week) requires restarting therapy with the loading dose.

Crushing, chewing, or splitting tablets

Relugolix tablets are film-coated. Crushing or chewing them is not recommended because this can alter the rate at which the drug is released and absorbed. Always swallow the tablet whole with water.

Taking Orgovyx with interacting medicines

Relugolix is a substrate of the P-gp transporter and CYP3A enzymes. The label advises avoiding oral P-gp inhibitors, such as certain antibiotics, antivirals, and antifungal agents, because they can increase drug exposure.

If co-administration cannot be avoided, take Orgovyx first and separate the doses by at least six hours. Treatment may be interrupted for up to two weeks if a short course of a P-gp inhibitor is required.

For medicines that are combined with P-gp and strong CYP3A inducers (e.g., rifampin, carbamazepine, or St John’s wort), avoid co-administration. If unavoidable, increase the Orgovyx dose to 240 mg once daily and resume the 120 mg dose after discontinuing the inducer.

Failing to restart with a loading dose after interruptions

Stopping the drug for more than seven days can allow testosterone levels to rebound. If therapy is interrupted for more than a week, restart with the 360 mg loading dose and then resume the daily 120 mg. Missing this step may lead to incomplete hormone suppression.

Ignoring contraceptive advice

Although Orgovyx is not used in women, its mechanism can cause embryo-fetal toxicity. The label advises males with female partners of reproductive potential to use effective contraception during treatment and for two weeks after the last dose.

Tips for staying on schedule

Maintaining a routine helps ensure you never miss a dose. Here are practical suggestions:

  • Use reminders. Set alarms on your phone to remember the daily dose.
  • Align dosing with a daily habit. Take the tablet with breakfast or another regular event to build consistency. Food does not affect absorption.
  • Travel smart. Bring enough tablets for the entire trip, plus a few extra in case of delays. Keep them in their original container to protect from moisture and to retain labelling.
  • Plan for drug interactions. Talk with your healthcare provider before starting any new medication. If you need a short course of a P-gp inhibitor, ask whether a temporary interruption is safe.
  • Monitor your health. Regular blood tests for prostate-specific antigen (PSA) and testosterone help confirm that the drug is working. If PSA rises, testosterone levels should be checked.

How to store and handle Orgovyx tablets

Keep Orgovyx in its original bottle and store it at room temperature in a dry area, unless your doctor or pharmacist instructs otherwise. Do not transfer the tablets into a weekly pill organizer. Always store the container safely away from children and pets.

If someone helps you with your medication, they may wear gloves or carefully pour the tablets from the bottle into the cap, a small cup, or directly into your hand to limit direct contact.

Hands should be washed thoroughly before and after handling the medication. Women who are pregnant or breastfeeding should not handle the tablets.

Speak with your oncology team about the proper way to dispose of any unused medication. Do not flush tablets down the toilet or discard them in household trash.

Bottom line

Orgovyx offers the convenience of a once-daily pill for androgen deprivation therapy, but its effectiveness depends on correct dosing. Start with the three-tablet loading dose, follow the 120 mg daily routine, handle missed doses appropriately, and consult your clinician about any other medicines you take. By avoiding common mistakes and following the advice above, you can maximise the benefits of Orgovyx while minimising risks.

Related Articles

Frequently Asked Questions

Yes. Abiraterone (Zytiga) is often used with ongoing androgen deprivation therapy, and Orgovyx can serve as the testosterone-lowering component. This combination may be used in advanced prostate cancer under oncology supervision. Monitoring of liver function, potassium, and testosterone levels is important.

Orgovyx (relugolix) lowers testosterone production by blocking GnRH receptors. Erleada (apalutamide) blocks the androgen receptor so cancer cells cannot use testosterone. They work in different ways and are sometimes used together.

Yes, but drug interactions are possible. Medications that strongly affect P-gp or CYP3A enzymes can change relugolix levels. Always review prescription drugs, over-the-counter products, and supplements with your doctor.

In clinical trials, 97% of men taking Orgovyx lowered their testosterone below 50 ng/dL by day 29 and lowered PSA levels by 92% after 3 months.

Erleada is taken once daily, with or without food. The best time is one you can take each day consistently. Taking it at the same time helps maintain steady levels.

Erleada is a strong CYP3A inducer and can lower the effectiveness of certain drugs, including some anticoagulants, anticonvulsants, and hormonal therapies. It may also affect medications processed by CYP2C9 and CYP2C19. A full medication review is recommended before starting treatment.

Stroke has been reported as part of major cardiovascular events during hormone therapy. In trials, serious heart-related events occurred but were less frequent with relugolix compared to leuprolide. Patients with existing cardiovascular disease should be monitored closely.

Testosterone levels usually begin to recover after discontinuation. In studies, many men showed recovery within about three months. PSA levels may rise if cancer remains hormone-sensitive.

Many US pharmacies charge more than $2,300 for a 30-day supply, and some reports list prices closer to $2,787 per month. If you have a valid prescription, you may be able to order Orgovyx through Pharma Giant, where prices start at $419.99.

No. Orgovyx is a hormone therapy. It works by suppressing testosterone rather than killing rapidly dividing cells.

Orgovyx effectively lowers testosterone without causing an initial hormone surge. It works quickly and is taken orally once daily. In clinical trials, it showed a lower rate of major cardiovascular events compared with leuprolide.

All androgen deprivation therapies can affect cardiovascular health. However, relugolix showed fewer major adverse cardiovascular events than leuprolide in the HERO trial. Patients with heart disease should still be monitored.

Avoid grapefruit or grapefruit juice while taking Orgovyx, as it can increase the drug’s concentration in your body. Always confirm with your healthcare provider if you have concerns about diet or supplements.

Sources

Leal, F., De Figueiredo, M. a. N., & Sasse, A. D. (2015). Optimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk non-metastatic prostate cancer: A systematic review and meta-analysis. International Braz J Urol, 41(3), 425–434. https://doi.org/10.1590/s1677-5538.ibju.2014.0412

Canadian Agency for Drugs and Technologies in Health. (2024, October 1). Clinical review. Relugolix (Orgovyx) – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK610041/

Cancer Resources from OncoLink, Treatment, Research, Coping, Clinical Trials, Prevention. (n.d.). Relugolix (OrgovyxTM) | OncoLink. University of Pennsylvania – OncoLink. https://www.oncolink.org/cancer-treatment/oncolink-rx/relugolix-orgovyx

Brown, G., Belkoff, L., Hafron, J. M., Saltzstein, D. R., Potdar, R., Bhaumik, A., Phillips, J., McGowan, T., & Shore, N. D. (2022). Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases. Targeted Oncology, 18(1), 95–103. https://doi.org/10.1007/s11523-022-00932-8

About Orgovyx. (n.d.). ORGOVYX. https://www.orgovyx.com/about-orgovyx/